ARTICLE SUMMARY:
Device makers are looking to the agency’s new guidance as a step toward stricter enforcement of the “third party” firms that hospitals contract to service imaging devices and other capital equipment.
FDA’s effort to define “remanufacturing” in a draft guidance last week is a positive step toward addressing shortfalls in the third-party device servicing sector, but FDA must follow up with enforcement, imaging companies say.
